ENV Share Price | Enervit SpA Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Enervit SpA with Similar Stocks

Shedir Pharma Group SpA Pierrel SpA Pharmanutra SpA

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Operating profit has grown by an annual rate -9.24% of over the last 5 years

Flat results in Jun 25

With ROE of 3.09%, it has a Very Expensive valuation with a 2.54 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 73 Million ()

P/E

82.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.15

Return on Equity

3.08%

Price to Book

2.23

Revenue and Profits:

Net Sales:

13 Million

(Quarterly Results - Dec 2015)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

8.38%

6 Months

-0.48%

1 Year

27.38%

2 Years

32.69%

3 Years

26.99%

4 Years

12.5%

5 Years

21.05%

Enervit SpA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

5.16%

EBIT Growth (5y)

-9.24%

EBIT to Interest (avg)

2.04

Debt to EBITDA (avg)

0.19

Net Debt to Equity (avg)

-0.11

Sales to Capital Employed (avg)

1.25

Tax Ratio

41.15%

Dividend Payout Ratio

69.05%

Pledged Shares

Institutional Holding

ROCE (avg)

12.42%

ROE (avg)

9.41%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.54

EV to EBIT

67.87

EV to EBITDA

27.59

EV to Capital Employed

2.73

EV to Sales

1.51

PEG Ratio

Dividend Yield

ROCE (Latest)

4.02%

ROE (Latest)

3.09%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'15 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is -5.30% vs 2.33% in Dec 2014",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is 33.33% vs -50.00% in Dec 2014",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'15",
        "Dec'14",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.50",
          "val2": "13.20",
          "chgp": "-5.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.80",
          "val2": "0.90",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.40",
          "val2": "0.30",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.40%",
          "val2": "25.00%",
          "chgp": "-0.26%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.23% vs 11.93% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.50% vs -4.76% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "96.70",
          "val2": "85.40",
          "chgp": "13.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.40",
          "val2": "8.50",
          "chgp": "-1.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.40",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.10",
          "val2": "4.00",
          "chgp": "2.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.20%",
          "val2": "54.00%",
          "chgp": "-0.48%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'15 - YoY

Dec'15

Dec'14

Change(%)

Net Sales

12.50

13.20

-5.30%

Operating Profit (PBDIT) excl Other Income

0.80

0.90

-11.11%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

0.40

0.30

33.33%

Operating Profit Margin (Excl OI)

22.40%

25.00%

-0.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2015 is -5.30% vs 2.33% in Dec 2014

Consolidated Net Profit

YoY Growth in quarter ended Dec 2015 is 33.33% vs -50.00% in Dec 2014

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

96.70

85.40

13.23%

Operating Profit (PBDIT) excl Other Income

8.40

8.50

-1.18%

Interest

0.50

0.40

25.00%

Exceptional Items

0.30

0.00

Consolidate Net Profit

4.10

4.00

2.50%

Operating Profit Margin (Excl OI)

49.20%

54.00%

-0.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 13.23% vs 11.93% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 2.50% vs -4.76% in Dec 2023

All Annual Results

Company CV

About Enervit SpA

Enervit SpA

Pharmaceuticals & Biotechnology

Enervit SpA is an Italy-based company engaged in the sports and nutrition market. It researches, develops and commercializes food supplements. The Company’s product lines include Enervit, a line of supplements for sport, efficiency, and muscular recovery before, during and after sports activity; Enerzona, a food supplement line that targets the wellness market, which includes snacks, diet food and drinks, among others; EnervitProtein, which includes products aimed at the Health & Diet market; Gymline, which is a product line allowing to maintain the muscle tone and muscle development. It operates an online shop. Its products are exported to over 20 countries globally. Its products are manufactured in facility located in Zelbio in Italy. It operates through Zest 12 SA, Equipe Enervit Srl and SLORFELDT TRADING AB.

Company Coordinates

Company Details

Viale Achille Papa, 30 , MILANO None : 20149

Tel: 39 02 485631

https://www.enervit.com/it-it/

Registrar Details